Skip to main content
Erschienen in: Cardiovascular Toxicology 4/2010

01.12.2010

Evidence of Altered Cardiac Electrophysiology Following Prolonged Androgenic Anabolic Steroid Use

verfasst von: Nicholas Sculthorpe, Fergal Grace, Peter Jones, Bruce Davies

Erschienen in: Cardiovascular Toxicology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

The non-therapeutic use of androgenic anabolic steroids (AAS) is associated with sudden cardiac death. Despite this, there is no proposed mechanism by which this may occur. Signal-averaged ECG (SAECG) allows the assessment of cardiac electrical stability, reductions of which are a known risk factor for cardiac arrhythmias. The aim of the present study was to examine cardiac electrical stability using SAECG in a group (n = 15) of long-term AAS users (AAS use 21.3 ± 3.1 years) compared with a group (n = 15) of age-matched weight lifters (WL) and age-matched sedentary controls [C (n = 15)]. AS, WL and C underwent SAECG analysis at rest and following an acute bout of exercise to volitional exhaustion. SAECGs were analyzed using a 40 Hz filter and were averaged over 200 beats. Results indicate a non-significant trend for increased incidence of abnormal SAECG measures at rest in AS (P = 0.55). However, AS demonstrated a significantly higher incidence of abnormalities of SAECG following exercise than C or WL (P < 0.05). In conclusion, the higher incidence of abnormal SAECG measurements immediately post-exercise in the AAS group places them at a greater risk of sudden death. The present study provides a strong contraindication to the use of AAS.
Literatur
1.
Zurück zum Zitat Fineschi, V., Baroldi, G., Monciotti, F., Paglicci Reattelli, L., & Turillazzi, E. (2001). Anabolic steroid abuse and cardiac sudden death: A pathologic study. Archives of Pathology and Laboratory Medicine, 125(2), 253–255.PubMed Fineschi, V., Baroldi, G., Monciotti, F., Paglicci Reattelli, L., & Turillazzi, E. (2001). Anabolic steroid abuse and cardiac sudden death: A pathologic study. Archives of Pathology and Laboratory Medicine, 125(2), 253–255.PubMed
2.
Zurück zum Zitat Fineschi, V., Riezzo, I., Centini, F., Silingardi, E., Licata, M., Beduschi, G., et al. (2007). Sudden cardiac death during anabolic steroid abuse: Morphologic and toxicologic findings in two fatal cases of bodybuilders. International Journal of Legal Medicine, 121(1), 48–53.CrossRefPubMed Fineschi, V., Riezzo, I., Centini, F., Silingardi, E., Licata, M., Beduschi, G., et al. (2007). Sudden cardiac death during anabolic steroid abuse: Morphologic and toxicologic findings in two fatal cases of bodybuilders. International Journal of Legal Medicine, 121(1), 48–53.CrossRefPubMed
3.
Zurück zum Zitat Graham, M. R., Grace, F. M., Boobier, W., Hullin, D., Kicman, A., Cowan, D., et al. (2006). Homocysteine induced cardiovascular events: A consequence of long term anabolic-androgenic steroid (AAS) abuse. British Journal of Sports Medicine, 40(7), 644–648.CrossRefPubMed Graham, M. R., Grace, F. M., Boobier, W., Hullin, D., Kicman, A., Cowan, D., et al. (2006). Homocysteine induced cardiovascular events: A consequence of long term anabolic-androgenic steroid (AAS) abuse. British Journal of Sports Medicine, 40(7), 644–648.CrossRefPubMed
4.
Zurück zum Zitat Breithardt, G., Cain, M. E., el-Sherif, N., Flowers, N. C., Hombach, V., Janse, M., et al. (1991). Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: A statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Journal of the American College of Cardiology, 17(5), 999–1006.CrossRefPubMed Breithardt, G., Cain, M. E., el-Sherif, N., Flowers, N. C., Hombach, V., Janse, M., et al. (1991). Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: A statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. Journal of the American College of Cardiology, 17(5), 999–1006.CrossRefPubMed
5.
Zurück zum Zitat Fauchier, J. P., Fauchier, L., Babuty, D., & Cosnay, P. (1996). Time-domain signal-averaged electrocardiogram in nonischemic ventricular tachycardia. Pacing and Clinical Electrophysiology, 19(2), 231–244.CrossRefPubMed Fauchier, J. P., Fauchier, L., Babuty, D., & Cosnay, P. (1996). Time-domain signal-averaged electrocardiogram in nonischemic ventricular tachycardia. Pacing and Clinical Electrophysiology, 19(2), 231–244.CrossRefPubMed
6.
Zurück zum Zitat Breithardt, G., Wichter, T., Fetsch, T., Seifert, T., Borggrefe, M., Shenasa, M., et al. (1993). The signal-averaged ECG: Time-domain analysis. European Heart Journal, 14(Suppl E), 27–32.PubMed Breithardt, G., Wichter, T., Fetsch, T., Seifert, T., Borggrefe, M., Shenasa, M., et al. (1993). The signal-averaged ECG: Time-domain analysis. European Heart Journal, 14(Suppl E), 27–32.PubMed
7.
Zurück zum Zitat Welder, A. A., Robertson, J. W., Fugate, R. D., & Melchert, R. B. (1995). Anabolic-androgenic steroid-induced toxicity in primary neonatal rat myocardial cell cultures. Toxicology and Applied Pharmacology, 133(2), 328–342.CrossRefPubMed Welder, A. A., Robertson, J. W., Fugate, R. D., & Melchert, R. B. (1995). Anabolic-androgenic steroid-induced toxicity in primary neonatal rat myocardial cell cultures. Toxicology and Applied Pharmacology, 133(2), 328–342.CrossRefPubMed
8.
Zurück zum Zitat LeGros, T., McConnell, D., Murry, T., Edavettal, M., Racey-Burns, L. A., Shepherd, R. E., et al. (2000). The effects of 17 alpha-methyltestosterone on myocardial function in vitro. Medicine and Science in Sports and Exercise, 32(5), 897–903.PubMed LeGros, T., McConnell, D., Murry, T., Edavettal, M., Racey-Burns, L. A., Shepherd, R. E., et al. (2000). The effects of 17 alpha-methyltestosterone on myocardial function in vitro. Medicine and Science in Sports and Exercise, 32(5), 897–903.PubMed
9.
Zurück zum Zitat Fanton, L., Belhani, D., Vaillant, F., Tabib, A., Gomez, L., Descotes, J., et al. (2009). Heart lesions associated with anabolic steroid abuse: Comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits. Experimental and Toxicologic Pathology, 61(4), 317–323.CrossRefPubMed Fanton, L., Belhani, D., Vaillant, F., Tabib, A., Gomez, L., Descotes, J., et al. (2009). Heart lesions associated with anabolic steroid abuse: Comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits. Experimental and Toxicologic Pathology, 61(4), 317–323.CrossRefPubMed
10.
Zurück zum Zitat D’Andrea, A., Caso, P., Salerno, G., Scarafile, R., De Corato, G., Mita, C., et al. (2007). Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: A Doppler myocardial and strain imaging analysis. British Journal of Sports Medicine, 41(3), 149–155.CrossRefPubMed D’Andrea, A., Caso, P., Salerno, G., Scarafile, R., De Corato, G., Mita, C., et al. (2007). Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: A Doppler myocardial and strain imaging analysis. British Journal of Sports Medicine, 41(3), 149–155.CrossRefPubMed
11.
Zurück zum Zitat Grace, F., Sculthorpe, N., Baker, J., & Davies, B. (2003). Blood pressure and rate pressure product response in males using high-dose anabolic androgenic steroids (AAS). Journal of Science and Medicine in Sport, 6(3), 307–312.CrossRefPubMed Grace, F., Sculthorpe, N., Baker, J., & Davies, B. (2003). Blood pressure and rate pressure product response in males using high-dose anabolic androgenic steroids (AAS). Journal of Science and Medicine in Sport, 6(3), 307–312.CrossRefPubMed
12.
Zurück zum Zitat Chung, T., Kelleher, S., Liu, P. Y., Conway, A. J., Kritharides, L., & Handelsman, D. J. (2007). Effects of testosterone and nandrolone on cardiac function: A randomized, placebo-controlled study. Clinical Endocrinology (Oxf), 66(2), 235–245.CrossRef Chung, T., Kelleher, S., Liu, P. Y., Conway, A. J., Kritharides, L., & Handelsman, D. J. (2007). Effects of testosterone and nandrolone on cardiac function: A randomized, placebo-controlled study. Clinical Endocrinology (Oxf), 66(2), 235–245.CrossRef
13.
Zurück zum Zitat Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513–554.CrossRefPubMed Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513–554.CrossRefPubMed
14.
Zurück zum Zitat Grace, F., Baker, J., & Davies, B. (2001). Anabolic androgenic steroid use in recreational gym users: A regional sample of the Mid-Glamorgan area. Journal of Substance Use, 6, 189–195.CrossRef Grace, F., Baker, J., & Davies, B. (2001). Anabolic androgenic steroid use in recreational gym users: A regional sample of the Mid-Glamorgan area. Journal of Substance Use, 6, 189–195.CrossRef
15.
Zurück zum Zitat Simpson, C. S., & MacFarlane, P. W. (1989). The signal averaged electrocardiogram. Comprehensive electrocardiology. NY: Pergamon Press. Simpson, C. S., & MacFarlane, P. W. (1989). The signal averaged electrocardiogram. Comprehensive electrocardiology. NY: Pergamon Press.
16.
Zurück zum Zitat Spach, M. S., & Dolber, P. C. (1986). Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circulation Research, 58(3), 356–371.PubMed Spach, M. S., & Dolber, P. C. (1986). Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circulation Research, 58(3), 356–371.PubMed
17.
Zurück zum Zitat Altman, (Ed.) 1991 Practical Statistics for Medical research (1st ed.). Chapman and Hall London. Altman, (Ed.) 1991 Practical Statistics for Medical research (1st ed.). Chapman and Hall London.
18.
Zurück zum Zitat Korkia, P., & Stimpson, G. V. (1993). Anabolic steroid use in Great Britain. London: The Center for Research on Drugs and Health Behavior. Korkia, P., & Stimpson, G. V. (1993). Anabolic steroid use in Great Britain. London: The Center for Research on Drugs and Health Behavior.
19.
Zurück zum Zitat Mochizuki, R. M., & Richter, K. J. (1988). Cardiomyopathy and cerbrovascular accident assosciated with anabolic androgenic steroid abuse. Physician and Sportsmedicine, 16, 108–114. Mochizuki, R. M., & Richter, K. J. (1988). Cardiomyopathy and cerbrovascular accident assosciated with anabolic androgenic steroid abuse. Physician and Sportsmedicine, 16, 108–114.
20.
Zurück zum Zitat Nieminen, M. S., Ramo, M. P., Viitasalo, M., Heikkila, P., Karjalainen, J., Mantysaari, M., et al. (1996). Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. European Heart Journal, 17(10), 1576–1583.PubMed Nieminen, M. S., Ramo, M. P., Viitasalo, M., Heikkila, P., Karjalainen, J., Mantysaari, M., et al. (1996). Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. European Heart Journal, 17(10), 1576–1583.PubMed
21.
Zurück zum Zitat Moroe, K., Kimoto, K., Inoue, T., Annoura, M., Oku, K., Arakawa, K., et al. (1995). Evaluation of abnormal signal-averaged electrocardiograms in young athletes. Japanese Circulation Journal, 59(5), 247–256.PubMed Moroe, K., Kimoto, K., Inoue, T., Annoura, M., Oku, K., Arakawa, K., et al. (1995). Evaluation of abnormal signal-averaged electrocardiograms in young athletes. Japanese Circulation Journal, 59(5), 247–256.PubMed
22.
Zurück zum Zitat Chamiec, T., Kulakowski, P., & Ceremuzynski, L. (1995). Exercise producing alterations in the signal-averaged electrocardiogram in patients after myocardial infarction. European Heart Journal, 16(3), 354–359.PubMed Chamiec, T., Kulakowski, P., & Ceremuzynski, L. (1995). Exercise producing alterations in the signal-averaged electrocardiogram in patients after myocardial infarction. European Heart Journal, 16(3), 354–359.PubMed
23.
Zurück zum Zitat Melchert, R. B., & Welder, A. A. (1995). Cardiovascular effects of androgenic-anabolic steroids. Medicine and Science in Sports and Exercise, 27(9), 1252–1262.PubMed Melchert, R. B., & Welder, A. A. (1995). Cardiovascular effects of androgenic-anabolic steroids. Medicine and Science in Sports and Exercise, 27(9), 1252–1262.PubMed
24.
Zurück zum Zitat Franz, M. R., Bargheer, K., Rafflenbeul, W., Haverich, A., & Lichtlen, P. R. (1987). Monophasic action potential mapping in human subjects with normal electrocardiograms: Direct evidence for the genesis of the T wave. Circulation, 75(2), 379–386.PubMed Franz, M. R., Bargheer, K., Rafflenbeul, W., Haverich, A., & Lichtlen, P. R. (1987). Monophasic action potential mapping in human subjects with normal electrocardiograms: Direct evidence for the genesis of the T wave. Circulation, 75(2), 379–386.PubMed
25.
Zurück zum Zitat Glazer, G. (1991). Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Arch. Internal Medicine, 151(10), 1925–1933.CrossRef Glazer, G. (1991). Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Arch. Internal Medicine, 151(10), 1925–1933.CrossRef
26.
Zurück zum Zitat Christowski, K., Kozera, J., & Grucza, R. (2000). Medical consequences of anabolic steroid abuse. Biology of Sport, 17(2), 134–152. Christowski, K., Kozera, J., & Grucza, R. (2000). Medical consequences of anabolic steroid abuse. Biology of Sport, 17(2), 134–152.
27.
28.
Zurück zum Zitat Tagarakis, C. V., Bloch, W., Hartmann, G., Hollmann, W., & Addicks, K. (2000). Testosterone-propionate impairs the response of the cardiac capillary bed to exercise. Medicine and Science in Sports and Exercise, 32(5), 946–953.PubMed Tagarakis, C. V., Bloch, W., Hartmann, G., Hollmann, W., & Addicks, K. (2000). Testosterone-propionate impairs the response of the cardiac capillary bed to exercise. Medicine and Science in Sports and Exercise, 32(5), 946–953.PubMed
Metadaten
Titel
Evidence of Altered Cardiac Electrophysiology Following Prolonged Androgenic Anabolic Steroid Use
verfasst von
Nicholas Sculthorpe
Fergal Grace
Peter Jones
Bruce Davies
Publikationsdatum
01.12.2010
Verlag
Humana Press Inc
Erschienen in
Cardiovascular Toxicology / Ausgabe 4/2010
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-010-9090-y

Weitere Artikel der Ausgabe 4/2010

Cardiovascular Toxicology 4/2010 Zur Ausgabe